Latest News & Updates

Latest Articles
Expert Says Immunotherapy Not the
Katherine Thornton, MD, discusses the potential that immunotherapy agents could have in the field of sarcoma, as well as the role of genomic profiling in understanding the patients who may benefit from select treatments.
PUBLISHED: September 29, 2016
Study Shows Cervical Cancer Screening Reduces Mortality
Regular screening for cervical cancer was found to be associated with an overall mortality prevention rate of 83%.
PUBLISHED: September 29, 2016
Fewer GI, GU Toxicities With Postoperative Pelvic IMRT in Gynecologic Malignancies
Patients with endometrial and cervical cancer reported significantly less acute gastrointestinal toxicity when treated with pelvic intensity-modulated radiation therapy as opposed to standard pelvic radiation therapy.
PUBLISHED: September 29, 2016
Payers Manipulate Definition of Necessity
When it comes to health coverage, most Americans face an unnerving reality—they have no idea what is covered under their health insurance policy until they are affected by illness or disease.  
PUBLISHED: September 29, 2016
RT Plus Chemo Significantly Improves PFS in Follicular Lymphoma
Chemoradiation for early-stage, low-grade follicular lymphoma led to significant improvement in progression-free survival compared with involved-field radiotherapy alone.
PUBLISHED: September 28, 2016
Latest Peer Exchange Discussions
MDS: The Current Understanding in Molecular Testing and Biomarkers
Panelists James M. Foran, MD, FRCPC, and Azra Raza, MD, provide insight on the current understanding in molecular testing and biomarkers in myelodysplastic syndrome. View Now
ALK-Positive Lung Cancer
Panelists Mark A. Socinski, MD; Gregory J. Riely, MD, PhD; Jared Weiss, MD; Thomas E. Stinchcombe, MD; and Benjamin P. Levy, MD; provide insight on the treatment options in ALK-positive lung cancer. View Now
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 14th Annual International Congress on the Future of Breast Cancer®Oct 01, 20162.0
Community Practice Connections™: 16th Annual International Lung Cancer Congress®Oct 06, 20162.0
Emerging Approaches for Patients With Less Common LymphomasOct 20, 20161.0
Advances in Targeted Therapy: The Emerging Role of PARP Inhibitors in the Treatment of CancersOct 30, 20162.0
Publication Bottom Border
Border Publication